| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,027 |
3,901 |
$488K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,555 |
5,419 |
$458K |
| 87631 |
|
1,252 |
1,246 |
$188K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
968 |
921 |
$171K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
720 |
713 |
$93K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,510 |
1,492 |
$46K |
| 80053 |
Comprehensive metabolic panel |
3,147 |
3,002 |
$35K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,445 |
5,117 |
$31K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
100 |
100 |
$31K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
674 |
667 |
$28K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
761 |
750 |
$23K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
408 |
402 |
$16K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
178 |
176 |
$15K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,354 |
1,299 |
$14K |
| 80061 |
Lipid panel |
982 |
971 |
$14K |
| 80050 |
General health panel |
273 |
271 |
$13K |
| T1015 |
Clinic visit/encounter, all-inclusive |
241 |
82 |
$12K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
220 |
214 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
915 |
899 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
403 |
391 |
$7K |
| 87081 |
|
1,029 |
1,023 |
$6K |
| 83735 |
|
857 |
835 |
$6K |
| 81001 |
|
1,906 |
1,884 |
$6K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
181 |
180 |
$6K |
| 82728 |
|
484 |
474 |
$5K |
| 83615 |
|
732 |
611 |
$5K |
| 87797 |
|
169 |
166 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
435 |
409 |
$4K |
| 84484 |
|
408 |
379 |
$4K |
| 82607 |
|
273 |
271 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
134 |
133 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
134 |
133 |
$3K |
| 84439 |
|
412 |
404 |
$3K |
| 82746 |
|
255 |
253 |
$3K |
| 87480 |
|
116 |
116 |
$3K |
| 87660 |
|
116 |
116 |
$3K |
| 83690 |
|
395 |
392 |
$2K |
| 87510 |
|
116 |
116 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
100 |
97 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
78 |
78 |
$2K |
| 85730 |
|
202 |
199 |
$1K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
34 |
25 |
$1K |
| 83605 |
|
141 |
136 |
$1K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
35 |
35 |
$1K |
| 84703 |
|
99 |
99 |
$1K |
| 80076 |
|
104 |
103 |
$982.55 |
| 83540 |
|
125 |
124 |
$914.34 |
| 85610 |
|
246 |
241 |
$908.60 |
| 83721 |
|
78 |
76 |
$853.73 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
94 |
93 |
$757.41 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
54 |
52 |
$702.00 |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$647.40 |
| 84100 |
|
91 |
89 |
$581.00 |
| 83550 |
|
124 |
123 |
$535.23 |
| 71046 |
Radiologic examination, chest; 2 views |
32 |
32 |
$514.89 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
69 |
67 |
$434.70 |
| 84481 |
|
13 |
12 |
$334.75 |
| 84460 |
|
38 |
38 |
$285.12 |
| 84450 |
|
38 |
38 |
$282.24 |
| 82565 |
|
37 |
37 |
$246.75 |
| 87581 |
|
37 |
37 |
$245.63 |
| 85652 |
|
67 |
67 |
$198.56 |
| 86140 |
|
67 |
67 |
$185.36 |
| 81025 |
|
27 |
27 |
$139.32 |
| 85027 |
|
18 |
14 |
$123.99 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
19 |
19 |
$119.66 |
| 82043 |
|
13 |
13 |
$114.40 |
| 82570 |
|
13 |
13 |
$102.31 |
| 87077 |
|
13 |
12 |
$95.60 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
848 |
834 |
$66.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,787 |
1,667 |
$37.57 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,363 |
1,306 |
$6.96 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
663 |
648 |
$6.91 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
817 |
785 |
$4.36 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
67 |
65 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
177 |
167 |
$0.00 |
| 0353U |
|
22 |
22 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
25 |
12 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
12 |
12 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
358 |
349 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
157 |
151 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
25 |
25 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
39 |
38 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
13 |
13 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
12 |
12 |
$0.00 |